Transinsight Wins FutureSAX VC-Forum for Best Company

TransinsightFutureSAX invited venture capitalists and entrepreneurs from all over Germany to Dresden under the motto "Lift Off with Venture Capital - Emphasis on Technology and Environment." In front of 80 guests, among them 30 investors, the jury selected Transinsight with its software technology for knowledge-based information searches from seven finalists as the winner of the most promising investment.

"The jury choose the Transinsight team because of their excellent business concept and investment, as well as their convincing presentation", says futureSAX representative Kerstin Trautmann. She goes on to say: "the Businessplan-Wettbewerb Sachsen GmbH congratulates the winner for this outstanding success."

"We are proud our concept is regarded as outstanding by top-class investors", says Dr. Michael R. Alvers, CEO of Transinsight GmbH. He continues: "We created software with the potential to revolutionize information searching. Themed "Together we Search, Think, and Write", we raise searching to a new level. We do not rank search results, the user does! This fosters democracy and allows companies and others to save plenty of time, which then becomes available for other relevant tasks."

Mark Miller, CEO of CatCap and a member of the jury, is convinced that close cooperation between the university and new high-tech companies in Dresden will lead to success. "Transinsight GmbH, with its brand new search paradigm, is well-positioned in the rapidly growing information handling and knowledge management market," says Miller.

Related news articles:

About Transinsight
Founded in 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge-based technologies. The flagship product, www.gopubmed.com, a well established biomedical search engine, is the first knowledge-based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technical University Dresden. For further information, visit www.transinsight.com.

About the VC Forum futureSAX
FutureSAX hosted a venture capital forum near the Frauenkirche for intensive discourse between venture capital investors. This forum has been the only VC networking forum to date in Saxony. Companies in the fields of technology and environment from all over Germany looking for investors could apply for one of eight presentation slots. FutureSAX was supported by KPMG and 3i Deutschland GmbH as well as by cooperation partners CatCap GmbH, Neuhaus Partners GmbH, and F.A.Z.-Institut GmbH. Investors were given the chance to get to know different outstanding companies during a single day as well as to get in contact with many potential co-investors. Companies were given the opportunity to present themselves in front of a community of investors. After the presentations, companies and investors got together over refreshments for one-on-one discussions. For further information, visit www.futuresax.de.

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...